Hong Kong
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.99 B
|
Dec. 31, 2023 | USD 0.67 | 1.15% |
|
Hong Kong |
|
2 |
USD 854.36 M
|
Dec. 31, 2023 | USD 0.38 | 2.08% |
|
Hong Kong |
|
3 |
USD 352.53 M
|
Dec. 31, 2023 | USD 0.93 | 2.39% |
|
Hong Kong |
|
4 |
USD 343.59 M
|
Dec. 31, 2023 | USD 1.48 | 0.68% |
|
Hong Kong |
|
5 |
USD 219.26 M
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
6 |
USD 164.63 M
|
Dec. 31, 2023 | USD 0.25 | -2.07% |
|
Hong Kong |
|
7 |
USD 149.49 M
|
March 31, 2024 | USD 0.46 | 4.31% |
|
Hong Kong |
|
8 |
USD 118.52 M
|
Dec. 31, 2023 | USD 0.41 | 0.30% |
|
Hong Kong |
|
9 |
USD 73.71 M
|
Dec. 31, 2023 | USD 0.52 | 0.23% |
|
Hong Kong |
|
10 |
USD 63.51 M
|
March 31, 2024 | USD 0.27 | 0.46% |
|
Hong Kong |
|
11 |
USD 59.00 M
|
Dec. 31, 2023 | USD 1.07 | 3.09% |
|
Hong Kong |
|
12 |
USD 47.66 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
13 |
USD 45.02 M
|
Dec. 31, 2023 | USD 0.80 | 2.57% |
|
Hong Kong |
|
14 |
USD 44.50 M
|
Dec. 31, 2023 | USD 0.19 | -0.02% |
|
Hong Kong |
|
15 |
USD 39.74 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
16 |
USD 23.03 M
|
Dec. 31, 2023 | USD 0.44 | 1.16% |
|
Hong Kong |
|
17 |
USD 14.09 M
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
18 |
USD 1.52 M
|
Dec. 31, 2023 | USD 0.43 | -0.61% |
|
Hong Kong |
|
19 |
USD -4.00 M
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
|
20 |
USD -13.76 M
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
21 |
USD -18.85 M
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
22 |
USD -70.29 M
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
|
23 |
USD -1.16 B
|
Dec. 31, 2023 | USD 17.19 | 2.12% |
|
Hong Kong |
The Healthcare company in Hong Kong with the highest Operating Cash Flow is China Resources Pharmaceutical Group Limited (HKSE: 3320.HK) at USD 1.99 B.
The Healthcare company in Hong Kong with the lowest Operating Cash Flow is BeiGene, Ltd. (HKSE: 6160.HK) at USD -1.16 B.
The top 10 Healthcare companies in Hong Kong by Operating Cash Flow are China Resources Pharmaceutical Group Limited, Sino Biopharmaceutical Limited, China Medical System Holdings Limited, The United Laboratories International Holdings Limited, HUTCHMED (China) Limited, China Traditional Chinese Medicine Holdings Co. Limited, Alibaba Health Information Technology Limited, SSY Group Limited, Modern Dental Group Limited and Perfect Medical Health Management Limited.
The bottom 10 Healthcare companies in Hong Kong by Operating Cash Flow are BeiGene, Ltd., Sirnaomics Ltd., SinoMab BioScience Limited, Prenetics Global Limited, Regencell Bioscience Holdings Limited, Tycoon Group Holdings Limited, Lee's Pharmaceutical Holdings Limited, OrbusNeich Medical Group Holdings Limited, Frontage Holdings Corporation and Jilin Province Huinan Changlong Bio-pharmacy Company Limited.